Drawing for ONEFOUR BIO

USPTO serial 79436629

ONEFOUR BIO

Reviewed by CopyMark Law Group

Reg. 8481177Status 700Registered
Filing date
Status date
Registration date
Oct 6, 2026
Examiner
DWYER, JOHN D
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONEFOUR BIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemical preparations for use in science, research and development, namely multivalent proteins and antibodies, for use in the fields of immuno-oncology, inflammation, auto-immune and hematological conditions and diseasesACTIVE—
005Pharmaceutical and veterinary preparations prepared with multivalent proteins and antibodies for the treatment of immune-oncology, auto-immune and hematological conditions and diseases in the biotechnology, pharmaceutical, biopharmaceutical and medical industriesACTIVE—
042Biochemistry consultation, research and advisory services for medical research laboratory and scientific laboratory, namely bacteriological and biochemical laboratories; preparation of scientific research reports by scientists, engineers, analysts, laboratory assistants and technicians, for industry and government services; scientific research, industrial research and search in the nature of biotechnological, pharmaceutical, biopharmaceutical and medical research and development of new products for third parties, in the field of multivalent proteins and antibodies, in the fields of immuno-oncology, auto-immune and hematological conditions and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2026LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Jul 22, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 1, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 28, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 28, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 28, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 7, 2026RHRDRESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED—
Mar 19, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 22, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 5, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 4, 2026RFRRREFUSAL PROCESSED BY MPU—
Nov 25, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2025DOCKASSIGNED TO EXAMINER—
Nov 17, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance